SlideShare a Scribd company logo
ANALYTICAL STUDY
Dr Payal
Resident doctor,
IGGMC Nagpur
Contents
•Introduction
•Epidemiology
•Methodology
•Study design
Introduction
• Epidemiology : ( comes from a Greek epidemic
meaning upon the people)
“Epi” –among, “demio”-population, “logy”-
study.
• The study of distribution and determinants of
health related states or events in specified
populations and the application of this study
to the prevention and control of health
problems.
Dr. JOHN.M.LAST
 Distribution: Time, Place, Person
 Determinants: Causes or risk factors
 Frequency: Incidence, Prevalence
 Distribution of disease:
 Time- seasonal(e.g.URTI in winter)
Place- geographical( Kala azar in UP,BIHAR,WB
Person- age(measles in 6month to 3 years, RF
in 5to 15 years, cataract in>55yrs)
-sex (migrain, DM in females, RTA in
males)
Epidemiological Purposes in Public
Health Practice
• Discover the agent, host and environmental
factors that affect health.
• Determine the relative importance of causes
(risk factors) of illness, disability and death.
• Evaluate the effectiveness of health programs
and services in improving population health.
Classification of Epidemiological
Studies
Epidemiological Study
Type
Observational
Experimental
Descriptive
Analytic
Epidemiological Studies
1) Observational studies : The investigator
measures but do not intervene.
Descriptive study :
• It is a first step in an Epidemiological Studies.
• Defining the population(Unit of study is entire
population)
• Defining the disease (Inclusion , exclusion and
diagnostic criteria)
• Description of the occurrence of a disease in a
population in terms of time, place ,person.
• Measurements of disease.
• Comparing with known indices.
• This study helps to generate the hypothesis.
(Hypothesis: It is a logical supposition, a
reasonable guess. Assumption without proof)
Analytical study :
• Second major type
• This study analyses the relationship between
health status and other variables.
• Unit of study is individual.
• This study helps to test the hypothesis.
2) Experimental study : aka Intervention study
• This study confirm the hypothesis.
• It involves an active attempt to change a
disease determinant such as an exposure or a
behaviour or the progress of a disease
through treatment.
• These studies are similar in design to
experiments in other sciences.
1)CROSS SECTIONAL STUDY
• Aka prevalence study.
• It is simplest form of an observational study.
• Unit of study is individual.
• It is based on a single examination of cross
section of population at one point in time so
the results of which can be projected on
whole population.
• In this study, measurements of exposure and
effects(outcome) are made at the same time,
so this study is useful for investigating the
casual association.
• Study is similar to a survey in such a way that,
it provides a snapshot of the population at a
point in time. So also called as snap chat
study.
--(Ruspini,2002)
• Using this study, the epidemiologist defines
the target population, then collects data from
the population or a subset of the population
at one specific point in time.
• Participants are selected regardless of their
exposure or disease status.
• This study useful in sudden outbreak of
disease and for chronic diseases.
Cross sectional study continued……..
• For example ,in a study of prevalence of
hypertension, we collect data during survey
about age, gender, body weight, physical
exercise, salt intake and other variables.
• Study helps in assessing load of disease, needs,
resources, patterns of health utilization,
practices and knowledge attitudes.
• This study tells us about the distribution of a
disease in a population rather than its etiology.
Advantages
• Relatively quick and easy to conduct, no follow
up.
• Data related to all variables is collected at
once.
• Study includes multiple outcomes and
exposures.
• It is a best way to understand disease load and
plan health services.
• Generation of hypothesis.
Disadvantages
• It is difficult to find out whether the outcome
followed exposure in time or it is resulted due to
outcome.
• Not suitable for rare disease or disease with
shorter duration.
• Study measures prevalent cases( new and old
cases) rather than incident cases so we can’t
measure incidence.
• The associations obtained in this study would be
difficult to interpret.
2)CASE CONTROL STUDY
• Aka case referent or retrospective study.
• This is the first approach to test a casual
hypothesis.
• Study Disease > Risk factor ( Backward looking)
as the Investigator is looking backwards from the
disease to a possible cause.
• In this study, subjects are selected on the basis of
whether they do (cases) or do not (controls) have
the disease.
• The groups are compared with respect to the
proportion having a history of an exposure .
Framework of case control study
Suspected or risk
factors(Smoking)
Cases (Lung Cancer) Controls (No lung
Cancer)
Present a b
Absent c d
Total a+c b+d
Steps in Case Control Study
1) Selection of Case – A case is someone who has
disease under investigation.
• It should be objective in nature and should be followed
meticulously throughout the study.
• Cases should represent a specified population group on
the basis of disease, not exposure. For this one needs
diagnostic criteria of that particular disease and also
stage of the disease
• The Second criteria is related to eligibility. The old
cases or cases that have advanced stage of the disease
may not be eligible for inclusion in the study.
• Sources of cases :
1. Hospitals: From a single hospital or network
of hospitals either case series or a random
sample, admitted during a specified period of
time. ( convenient)
2. General population: selected in a
geographical area through survey, a disease
registry or hospital network.
2) Selection of control
• Control is someone who doesn’t have the
disease under investigation.
• Control should be similar to the cases as
possible except for the disease under study
• So controls should be indentified before the
study.
• Sources: controls from Hospital, relatives ,
neighbors, occupational associates or general
population..
3) Matching
• The controls may differ from the cases in a
number of factors such as age, sex, occupation,
education, social status etc.
• To share the comparability between cases and
controls matching is done.
• It is the process, by which select controls in such
a way that they are similar to cases with regard to
certain pertinent variables, which are known to
influence the outcome of the disease.
• If Matching not done ,this could distort or
confound the results.
• Confounding factor – Is defined as one which
is associated with both exposure and disease
and is distributed unequally in cases and
control group.
• Precautions while matching
- matching factor should be associated with
disease not on exposure
4)Measurements of exposure
• In this study, the exposure status of the cases is usually
determined after the development of the disease and
by Questionnaire, physical examination, laboratory
investigations and study of records.
• The exposure may be of various types.(e.g. habit of
alcohol drinking, smoking)
• The measurement of exposure can be done by various
methods. Such as estimation of causative agent in
environment (carbon monoxide in air), estimation of
pathological changes(RBC stripling,Hb level in lead
poisoning).
5) Analysis
• Final step in analysis, done to find out
(a) Exposure rates among cases and controls to
suspected factor : provides direct estimation
of exposure rates(frequency of exposure) to a
suspected factor in disease and non disease.
(b)Elimination of disease risk associated with
exposure.
Smoking Lung Cancer Not having Lung
cancer
Total
Exposure present 90(a) 20(b) 110
Exposure absent 10(c) 80(d) 90
Total 100 100 200
• Exposure rates:
 Cases = a /(a+c) = 90/100
Controls = b /(b+d) = 20/100
This shows that, frequency of lung cancer was
higher among smokers than among non
smokers.
Estimation of Risk
• It is obtained by Relative Risk(RR) or risk ratio is
defined as the ratio between the incidence of
disease among exposed persons and incidence
among non exposed.
Incidence among exposed
Relative risk =
Incidence among nonexposed
= a /(a+c) ÷ b /(b+d)
• A typical case control study, does not provide
incidence rate from which relative risk can be
calculated.
• Next step Is to estimate the risk of disease
associated with the exposure Odds ratio
(Cross product ratio) : Determine the
association of an exposure and a disease.
• It is similar to risk ratio
Derivation of odds ratio is on 3 assumptions:
• The disease under investigation must be
relatively rare.
• The cases must be representative of those
with the disease
• The controls must be free from disease.
• Odds ratio = ( a/ b)
( c/ d )
= ad / bc
= 90* 80/ 20* 10
= 7200 / 200
= 36
• Interpretation:
Odds ratio is 1 , no association
Odds ratio is >1 , positive association
Odds ratio is <1 , negative association
(protective effect)
In the above example, people who smoke(cases)
were having a risk of developing lung cancer
36 times that of non smokers.
Bias
• It is any systematic error in the determination
of the association between exposure and the
disease.
a) Bias due to confounding
b) Memory or recall bias
c) Selection bias
d) Berkesonian bias
e) Interviewers bias
Advantages
• Easy to conduct, consume less time,
inexpensive.
• Suitable for rare disease.
• There is no risk to the subjects as disease has
already occurred.
• It is possible to study different causative
factors responsible for a particular disease.
• Minimal ethical problem
Disadvantages
• Study depends upon on
history/records/memory.
• It is very difficult to get a perfect control.
Group.
• It is not possible to measure incidence and
relative risk.
• This study can not distinguish between causes
and associated factors
3) COHORT STUDY
• Cohort studies also called as Follow up ,
Incidence study, Prospective study, Forward
looking study or longitudinal study.
• Cohort study is similar to a longitudinal
descriptive study with exception that there is
comparison group in cohort.
• Cohort is defined as a group of people who
share a common characteristics or exposure
within a specified time period (Birth cohort).
• Cohort studies are indicated when there is good
evidence of association between exposure and
when exposure is rare and incidence is high.
• They are indicated when follow up is easy, cohort
is stable, cooperative and easily accessible and
ample funds are available.
• Cohorts must be free from the disease under
study and then they are classified into subgroups
according to exposure to a potential cause of
disease or outcome. And followed up for study
under same identical conditions.
• Both groups should be comparable in respect
of all the possible variables, which may
influence the frequency of disease.
• Diagnostic and eligibility criteria of disease
must be defined before the study.
Types of cohort
• 1.Prospective
• 2.Retrospective
• 3.Mixed
Steps of a cohort study
1) Selection of study subjects
a) General Population: people residing in well
defined geographical area.
b) Special groups: such as professional group,
governments employees, volunteers, etc.
these groups are usually homogeneous
population.
2) Obtaining data on exposure: data collected
through personal interviews, mailed
questionnaires, previous records, medical
examination or special tests.
• Groups are divided according to whether they
have been exposed to a suspected factor
(case) or not exposed (control) if yes then
divided again as per degree of exposure
3) Selection of comparison group:
Internal comparison: In some study no outside
comparison group required. On the basis of
information obtained single cohort group are
classified into several comparison groups
according to degree or level of exposure to risk
before development of disease.(e.g. smoking,
blood pressure)
External comparison: when degree or level of
exposure is not availble.
Comparison with general population: If none
available or the difficulties of selecting the
study and comparison group.
4) Follow up: It is a most important step. To obtain
data for assessing the outcome, the procedures
required,
A. Periodical medical examination of each member
of cohort as it provides more information.
B. Reviewing records from physicians and hospitals.
C. By surveillance of routine death records.
D. Mailed questionnaire, telephone calls and
periodic home visits on annual basis.
5) Analysis: In this study, we analysis data by
calculating incidence rates of disease for both
cohorts, and then estimating relative risk,
attributable risk and population attributable
risk.
Disease present Disease absent Total
Cause present a (30) b (70) a+b (100)
Cause absent c (10) d (90) c+d (100)
1. Relative Risk: It is defined as the ratio
between the incidence of disease among
exposed persons and incidence among non
exposed.
• In above example,
Incidence rate among smokers is=30/100
Incidence rate among non smokers is=10/100
• Therefore, Relative risk = 30/10 = 3.
• Relative risk has etiological enquiries as it
provides direct measure of the strength of
association between suspected cause or
exposure and effect.
• In this example, relative risk is 3 means people
who smoke cigarettes, have 3 times more risk
of developing lung cancers than non smokers.
2. Attributable risk/Risk difference: It is the
difference in incidence rates of disease
between exposed group and non exposed
group.
• It provides info. about the contribution of
suspected cause for the occurrence of disease.
(or how much of the disease can be attributed
to suspected cause.)
AR =
(Incidence of disease in exposed –
Incidence of disease in non exposed × 100
Incidence rate among exposed
• In this example,
AR= 0.3-0.1 × 100
0.3
= 0.2/0.1 × 100
= 66%
• So in this example, It shows that, 66% of the lung
cancers among smokers could be attributed to
smoking. And hence there is a causal association.
• This information helps in knowing how much
of the disease can be eliminated by
eliminating or controlling the suspected cause
under study.
3. Population attributable risk: It is the
incidence of the disease (or death) in the total
population minus incidence of the disease (or
death) among those who were not exposed to
the suspected causal factor.
• It provides an estimate of the amount by
which the disease could be reduced in that
population if the suspected cause or exposure
was eliminated or controlled.
Advantages
• We find out incidence.
• The beginning point is cohort with and
without exposure, so from this we can study
many outcomes related to exposure.
• Relative risk is being calculated.
• Minimal bias
Disadvantages
• Unsuitable for rare diseases.
• Time consuming. (migration, death ,behaviour
change or loss of interest, population attrition)
• Administrative problems( lack of experienced
staff, shortage of fund).
• Over a period of time, the diagnostic criteria or
definition of a disease under study may change.
• Expensive.
• Selection of comparison groups which are
representative of the exposed and unexposed
segments of the population is a limiting factor.
• Ethical issues.
Nested case control study
• It is a case control study “nested” within a
prospective or retrospective cohort study.
• In this study design, Cases and Controls both
are from cohort sample.
• It is useful for predictor variables that are
expensive, useful for costly analysis of
specimens, like biochemical analysis of serum
samples that are taken at the beginning of the
study and then preserved for later analysis.
• STEPS :
• Identify a cohort with a pool of specimens
collected at baseline.
• Identify those developing disease during
follow up(Cases).
• Select the sample from cohort who do not
develop the disease(Control)
• Measure the predictor variables.
4)Ecological study
• Aka correlational study
• Useful for generating hypothesis
• Units of analysis are groups of people
• These studies can be done by comparing
populations in different places at same time or
in a time series or comparing same population
at one place at different time.
Drawbacks
• As it is easy to conduct, attractive, these study
are often difficult to interpret.
• Ecological studies usually rely on data
collected for other purposes.
• The association between exposure and effect
at the individual level cant be made.
• Ecological fallacy: bias results from if
inappropriate conclusions are drawn on the
basis of ecological data.
References
Study Design Flow Chart
THANK YOU

More Related Content

What's hot

Epidemiology of chronic non communicable diseases.pptx
Epidemiology of chronic non communicable diseases.pptxEpidemiology of chronic non communicable diseases.pptx
Epidemiology of chronic non communicable diseases.pptx
Romy Markose
 
Cross sectional study overview
Cross sectional study overviewCross sectional study overview
Cross sectional study overviewherunyu
 
Screening tests
Screening  testsScreening  tests
Screening tests
monaaboserea
 
The odds ratio
The odds ratioThe odds ratio
The odds ratio
Ramachandra Barik
 
Standardization of rates
Standardization of ratesStandardization of rates
Standardization of rates
Halyna Lugova
 
Effect size presentation.rob
Effect size presentation.robEffect size presentation.rob
Effect size presentation.rob
Rob Darrow
 
Screening
ScreeningScreening
Screening
Dalia El-Shafei
 
NVBDCP-GUJARAT
NVBDCP-GUJARATNVBDCP-GUJARAT
NVBDCP-GUJARAT
pushpamanjari
 
Incidence or incidence rate (Epidemiology short lecture)
Incidence or incidence rate (Epidemiology short lecture)Incidence or incidence rate (Epidemiology short lecture)
Incidence or incidence rate (Epidemiology short lecture)
Muhammad Akbar Rashid Qadri
 
Epidemiological Exercises on case control studies
Epidemiological Exercises on case control studiesEpidemiological Exercises on case control studies
Epidemiological Exercises on case control studies
Jayaramachandran S
 
Types of Screening
Types of ScreeningTypes of Screening
Types of Screening
Dr. Abraham Mallela
 
cohort study
 cohort study cohort study
cohort study
Pragyan Parija
 
Epidemiology class swati
Epidemiology class swatiEpidemiology class swati
Epidemiology class swati
Swati Sirwar
 
Introduction to DALY and burden of disease
Introduction to DALY and burden of diseaseIntroduction to DALY and burden of disease
Introduction to DALY and burden of disease
Dr Arindam Basu
 
DEFINITIONS
DEFINITIONSDEFINITIONS
DEFINITIONS
Shahzaib Khan
 
Range 1.1 and coeeficient of variance.
Range 1.1 and coeeficient of variance.Range 1.1 and coeeficient of variance.
Range 1.1 and coeeficient of variance.
SalesanddataAcademy
 
Epidemiological study designs
Epidemiological study designsEpidemiological study designs
Epidemiological study designs
Kayode Afolabi
 
6..Study designs in descritive epidemiology DR.SOMANATH.ppt
6..Study designs in descritive  epidemiology DR.SOMANATH.ppt6..Study designs in descritive  epidemiology DR.SOMANATH.ppt
6..Study designs in descritive epidemiology DR.SOMANATH.ppt
DentalYoutube
 
Epidemiological study designs
Epidemiological study designs Epidemiological study designs
Epidemiological study designs
Tauseef Jawaid
 
Basis of statistical inference
Basis of statistical inferenceBasis of statistical inference
Basis of statistical inferencezahidacademy
 

What's hot (20)

Epidemiology of chronic non communicable diseases.pptx
Epidemiology of chronic non communicable diseases.pptxEpidemiology of chronic non communicable diseases.pptx
Epidemiology of chronic non communicable diseases.pptx
 
Cross sectional study overview
Cross sectional study overviewCross sectional study overview
Cross sectional study overview
 
Screening tests
Screening  testsScreening  tests
Screening tests
 
The odds ratio
The odds ratioThe odds ratio
The odds ratio
 
Standardization of rates
Standardization of ratesStandardization of rates
Standardization of rates
 
Effect size presentation.rob
Effect size presentation.robEffect size presentation.rob
Effect size presentation.rob
 
Screening
ScreeningScreening
Screening
 
NVBDCP-GUJARAT
NVBDCP-GUJARATNVBDCP-GUJARAT
NVBDCP-GUJARAT
 
Incidence or incidence rate (Epidemiology short lecture)
Incidence or incidence rate (Epidemiology short lecture)Incidence or incidence rate (Epidemiology short lecture)
Incidence or incidence rate (Epidemiology short lecture)
 
Epidemiological Exercises on case control studies
Epidemiological Exercises on case control studiesEpidemiological Exercises on case control studies
Epidemiological Exercises on case control studies
 
Types of Screening
Types of ScreeningTypes of Screening
Types of Screening
 
cohort study
 cohort study cohort study
cohort study
 
Epidemiology class swati
Epidemiology class swatiEpidemiology class swati
Epidemiology class swati
 
Introduction to DALY and burden of disease
Introduction to DALY and burden of diseaseIntroduction to DALY and burden of disease
Introduction to DALY and burden of disease
 
DEFINITIONS
DEFINITIONSDEFINITIONS
DEFINITIONS
 
Range 1.1 and coeeficient of variance.
Range 1.1 and coeeficient of variance.Range 1.1 and coeeficient of variance.
Range 1.1 and coeeficient of variance.
 
Epidemiological study designs
Epidemiological study designsEpidemiological study designs
Epidemiological study designs
 
6..Study designs in descritive epidemiology DR.SOMANATH.ppt
6..Study designs in descritive  epidemiology DR.SOMANATH.ppt6..Study designs in descritive  epidemiology DR.SOMANATH.ppt
6..Study designs in descritive epidemiology DR.SOMANATH.ppt
 
Epidemiological study designs
Epidemiological study designs Epidemiological study designs
Epidemiological study designs
 
Basis of statistical inference
Basis of statistical inferenceBasis of statistical inference
Basis of statistical inference
 

Similar to ANALYTICAL STUDIES.pptx

Epidemiological study designs Part - I.pptx
Epidemiological study designs Part - I.pptxEpidemiological study designs Part - I.pptx
Epidemiological study designs Part - I.pptx
IsaacLalrawngbawla1
 
Epidemiology methods, approaches and tools of measurement
Epidemiology methods, approaches and tools of measurement Epidemiology methods, approaches and tools of measurement
Epidemiology methods, approaches and tools of measurement
Swapnilsalve1998
 
Epidemiological study designs
Epidemiological study designsEpidemiological study designs
Epidemiological study designs
jarati
 
2010-Epidemiology (Dr. Sameem) basics and priciples.ppt
2010-Epidemiology (Dr. Sameem) basics and priciples.ppt2010-Epidemiology (Dr. Sameem) basics and priciples.ppt
2010-Epidemiology (Dr. Sameem) basics and priciples.ppt
AmirRaziq1
 
Epidemiological Studies
Epidemiological StudiesEpidemiological Studies
Epidemiological Studies
INAAMUL HAQ
 
Seminar case control study
Seminar case control studySeminar case control study
Seminar case control study
Radhika Maniyar
 
study design1.pdf
study design1.pdfstudy design1.pdf
study design1.pdf
Josephmwanika
 
5. cohort studies
5. cohort  studies5. cohort  studies
5. cohort studies
Naveen Phuyal
 
Analytical epidemiology seminar 3.pptx
Analytical epidemiology seminar 3.pptxAnalytical epidemiology seminar 3.pptx
Analytical epidemiology seminar 3.pptx
drmamatanaik
 
Experimental Studies
Experimental StudiesExperimental Studies
Experimental Studies
Abhijit Das
 
Types of study design
Types of study designTypes of study design
Types of study design
Dipayan Banerjee
 
STUDY DESIGN in health and medical research .pptx
STUDY DESIGN in health and medical research .pptxSTUDY DESIGN in health and medical research .pptx
STUDY DESIGN in health and medical research .pptx
Abubakar Hammadama
 
Cohort study and case control study
Cohort study and case control studyCohort study and case control study
Cohort study and case control study
Niv09
 
Case_Control_Study.pptx
Case_Control_Study.pptxCase_Control_Study.pptx
Case_Control_Study.pptx
Royal Dental College Library
 
Epidemiology Concepts
Epidemiology ConceptsEpidemiology Concepts
Epidemiology Concepts
MANULALVS
 
Analytic upto surviellance
Analytic upto surviellanceAnalytic upto surviellance
Analytic upto surviellance
kaleabtegegne
 
Types of studies 2016
Types of studies 2016Types of studies 2016
Types of studies 2016
Ahmed Elfaitury
 
Epidemiology an introduction
Epidemiology an introductionEpidemiology an introduction
Epidemiology an introduction
Bhoj Raj Singh
 
Epidemiological concept
Epidemiological conceptEpidemiological concept
Epidemiological concept
sushantkarki4
 
Chapter 3 epidemiologic study design2008
Chapter 3 epidemiologic study design2008Chapter 3 epidemiologic study design2008
Chapter 3 epidemiologic study design2008
drtaa62
 

Similar to ANALYTICAL STUDIES.pptx (20)

Epidemiological study designs Part - I.pptx
Epidemiological study designs Part - I.pptxEpidemiological study designs Part - I.pptx
Epidemiological study designs Part - I.pptx
 
Epidemiology methods, approaches and tools of measurement
Epidemiology methods, approaches and tools of measurement Epidemiology methods, approaches and tools of measurement
Epidemiology methods, approaches and tools of measurement
 
Epidemiological study designs
Epidemiological study designsEpidemiological study designs
Epidemiological study designs
 
2010-Epidemiology (Dr. Sameem) basics and priciples.ppt
2010-Epidemiology (Dr. Sameem) basics and priciples.ppt2010-Epidemiology (Dr. Sameem) basics and priciples.ppt
2010-Epidemiology (Dr. Sameem) basics and priciples.ppt
 
Epidemiological Studies
Epidemiological StudiesEpidemiological Studies
Epidemiological Studies
 
Seminar case control study
Seminar case control studySeminar case control study
Seminar case control study
 
study design1.pdf
study design1.pdfstudy design1.pdf
study design1.pdf
 
5. cohort studies
5. cohort  studies5. cohort  studies
5. cohort studies
 
Analytical epidemiology seminar 3.pptx
Analytical epidemiology seminar 3.pptxAnalytical epidemiology seminar 3.pptx
Analytical epidemiology seminar 3.pptx
 
Experimental Studies
Experimental StudiesExperimental Studies
Experimental Studies
 
Types of study design
Types of study designTypes of study design
Types of study design
 
STUDY DESIGN in health and medical research .pptx
STUDY DESIGN in health and medical research .pptxSTUDY DESIGN in health and medical research .pptx
STUDY DESIGN in health and medical research .pptx
 
Cohort study and case control study
Cohort study and case control studyCohort study and case control study
Cohort study and case control study
 
Case_Control_Study.pptx
Case_Control_Study.pptxCase_Control_Study.pptx
Case_Control_Study.pptx
 
Epidemiology Concepts
Epidemiology ConceptsEpidemiology Concepts
Epidemiology Concepts
 
Analytic upto surviellance
Analytic upto surviellanceAnalytic upto surviellance
Analytic upto surviellance
 
Types of studies 2016
Types of studies 2016Types of studies 2016
Types of studies 2016
 
Epidemiology an introduction
Epidemiology an introductionEpidemiology an introduction
Epidemiology an introduction
 
Epidemiological concept
Epidemiological conceptEpidemiological concept
Epidemiological concept
 
Chapter 3 epidemiologic study design2008
Chapter 3 epidemiologic study design2008Chapter 3 epidemiologic study design2008
Chapter 3 epidemiologic study design2008
 

Recently uploaded

New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
NEHA GUPTA
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Oleg Kshivets
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
KafrELShiekh University
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
i3 Health
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
sisternakatoto
 
Pharma Pcd Franchise in Jharkhand - Yodley Lifesciences
Pharma Pcd Franchise in Jharkhand - Yodley LifesciencesPharma Pcd Franchise in Jharkhand - Yodley Lifesciences
Pharma Pcd Franchise in Jharkhand - Yodley Lifesciences
Yodley Lifesciences
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
MedicoseAcademics
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
kevinkariuki227
 
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfMANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
Jim Jacob Roy
 
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradeshBasavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Dr. Madduru Muni Haritha
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
Little Cross Family Clinic
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
greendigital
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
vimalpl1234
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
pal078100
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
NephroTube - Dr.Gawad
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
FFragrant
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
GL Anaacs
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
Savita Shen $i11
 

Recently uploaded (20)

New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
 
Pharma Pcd Franchise in Jharkhand - Yodley Lifesciences
Pharma Pcd Franchise in Jharkhand - Yodley LifesciencesPharma Pcd Franchise in Jharkhand - Yodley Lifesciences
Pharma Pcd Franchise in Jharkhand - Yodley Lifesciences
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
 
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfMANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
 
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradeshBasavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
 

ANALYTICAL STUDIES.pptx

  • 1. ANALYTICAL STUDY Dr Payal Resident doctor, IGGMC Nagpur
  • 3. Introduction • Epidemiology : ( comes from a Greek epidemic meaning upon the people) “Epi” –among, “demio”-population, “logy”- study. • The study of distribution and determinants of health related states or events in specified populations and the application of this study to the prevention and control of health problems.
  • 5.  Distribution: Time, Place, Person  Determinants: Causes or risk factors  Frequency: Incidence, Prevalence
  • 6.  Distribution of disease:  Time- seasonal(e.g.URTI in winter) Place- geographical( Kala azar in UP,BIHAR,WB Person- age(measles in 6month to 3 years, RF in 5to 15 years, cataract in>55yrs) -sex (migrain, DM in females, RTA in males)
  • 7. Epidemiological Purposes in Public Health Practice • Discover the agent, host and environmental factors that affect health. • Determine the relative importance of causes (risk factors) of illness, disability and death. • Evaluate the effectiveness of health programs and services in improving population health.
  • 8. Classification of Epidemiological Studies Epidemiological Study Type Observational Experimental Descriptive Analytic
  • 9. Epidemiological Studies 1) Observational studies : The investigator measures but do not intervene. Descriptive study : • It is a first step in an Epidemiological Studies. • Defining the population(Unit of study is entire population) • Defining the disease (Inclusion , exclusion and diagnostic criteria) • Description of the occurrence of a disease in a population in terms of time, place ,person.
  • 10. • Measurements of disease. • Comparing with known indices. • This study helps to generate the hypothesis. (Hypothesis: It is a logical supposition, a reasonable guess. Assumption without proof)
  • 11. Analytical study : • Second major type • This study analyses the relationship between health status and other variables. • Unit of study is individual. • This study helps to test the hypothesis.
  • 12. 2) Experimental study : aka Intervention study • This study confirm the hypothesis. • It involves an active attempt to change a disease determinant such as an exposure or a behaviour or the progress of a disease through treatment. • These studies are similar in design to experiments in other sciences.
  • 13. 1)CROSS SECTIONAL STUDY • Aka prevalence study. • It is simplest form of an observational study. • Unit of study is individual. • It is based on a single examination of cross section of population at one point in time so the results of which can be projected on whole population.
  • 14. • In this study, measurements of exposure and effects(outcome) are made at the same time, so this study is useful for investigating the casual association. • Study is similar to a survey in such a way that, it provides a snapshot of the population at a point in time. So also called as snap chat study. --(Ruspini,2002)
  • 15. • Using this study, the epidemiologist defines the target population, then collects data from the population or a subset of the population at one specific point in time. • Participants are selected regardless of their exposure or disease status. • This study useful in sudden outbreak of disease and for chronic diseases.
  • 16. Cross sectional study continued…….. • For example ,in a study of prevalence of hypertension, we collect data during survey about age, gender, body weight, physical exercise, salt intake and other variables. • Study helps in assessing load of disease, needs, resources, patterns of health utilization, practices and knowledge attitudes. • This study tells us about the distribution of a disease in a population rather than its etiology.
  • 17. Advantages • Relatively quick and easy to conduct, no follow up. • Data related to all variables is collected at once. • Study includes multiple outcomes and exposures. • It is a best way to understand disease load and plan health services. • Generation of hypothesis.
  • 18. Disadvantages • It is difficult to find out whether the outcome followed exposure in time or it is resulted due to outcome. • Not suitable for rare disease or disease with shorter duration. • Study measures prevalent cases( new and old cases) rather than incident cases so we can’t measure incidence. • The associations obtained in this study would be difficult to interpret.
  • 19. 2)CASE CONTROL STUDY • Aka case referent or retrospective study. • This is the first approach to test a casual hypothesis. • Study Disease > Risk factor ( Backward looking) as the Investigator is looking backwards from the disease to a possible cause. • In this study, subjects are selected on the basis of whether they do (cases) or do not (controls) have the disease. • The groups are compared with respect to the proportion having a history of an exposure .
  • 20. Framework of case control study Suspected or risk factors(Smoking) Cases (Lung Cancer) Controls (No lung Cancer) Present a b Absent c d Total a+c b+d
  • 21. Steps in Case Control Study 1) Selection of Case – A case is someone who has disease under investigation. • It should be objective in nature and should be followed meticulously throughout the study. • Cases should represent a specified population group on the basis of disease, not exposure. For this one needs diagnostic criteria of that particular disease and also stage of the disease • The Second criteria is related to eligibility. The old cases or cases that have advanced stage of the disease may not be eligible for inclusion in the study.
  • 22. • Sources of cases : 1. Hospitals: From a single hospital or network of hospitals either case series or a random sample, admitted during a specified period of time. ( convenient) 2. General population: selected in a geographical area through survey, a disease registry or hospital network.
  • 23. 2) Selection of control • Control is someone who doesn’t have the disease under investigation. • Control should be similar to the cases as possible except for the disease under study • So controls should be indentified before the study. • Sources: controls from Hospital, relatives , neighbors, occupational associates or general population..
  • 24. 3) Matching • The controls may differ from the cases in a number of factors such as age, sex, occupation, education, social status etc. • To share the comparability between cases and controls matching is done. • It is the process, by which select controls in such a way that they are similar to cases with regard to certain pertinent variables, which are known to influence the outcome of the disease. • If Matching not done ,this could distort or confound the results.
  • 25. • Confounding factor – Is defined as one which is associated with both exposure and disease and is distributed unequally in cases and control group. • Precautions while matching - matching factor should be associated with disease not on exposure
  • 26. 4)Measurements of exposure • In this study, the exposure status of the cases is usually determined after the development of the disease and by Questionnaire, physical examination, laboratory investigations and study of records. • The exposure may be of various types.(e.g. habit of alcohol drinking, smoking) • The measurement of exposure can be done by various methods. Such as estimation of causative agent in environment (carbon monoxide in air), estimation of pathological changes(RBC stripling,Hb level in lead poisoning).
  • 27. 5) Analysis • Final step in analysis, done to find out (a) Exposure rates among cases and controls to suspected factor : provides direct estimation of exposure rates(frequency of exposure) to a suspected factor in disease and non disease. (b)Elimination of disease risk associated with exposure.
  • 28. Smoking Lung Cancer Not having Lung cancer Total Exposure present 90(a) 20(b) 110 Exposure absent 10(c) 80(d) 90 Total 100 100 200
  • 29. • Exposure rates:  Cases = a /(a+c) = 90/100 Controls = b /(b+d) = 20/100 This shows that, frequency of lung cancer was higher among smokers than among non smokers.
  • 30. Estimation of Risk • It is obtained by Relative Risk(RR) or risk ratio is defined as the ratio between the incidence of disease among exposed persons and incidence among non exposed. Incidence among exposed Relative risk = Incidence among nonexposed = a /(a+c) ÷ b /(b+d)
  • 31. • A typical case control study, does not provide incidence rate from which relative risk can be calculated. • Next step Is to estimate the risk of disease associated with the exposure Odds ratio (Cross product ratio) : Determine the association of an exposure and a disease. • It is similar to risk ratio
  • 32. Derivation of odds ratio is on 3 assumptions: • The disease under investigation must be relatively rare. • The cases must be representative of those with the disease • The controls must be free from disease.
  • 33. • Odds ratio = ( a/ b) ( c/ d ) = ad / bc = 90* 80/ 20* 10 = 7200 / 200 = 36
  • 34. • Interpretation: Odds ratio is 1 , no association Odds ratio is >1 , positive association Odds ratio is <1 , negative association (protective effect) In the above example, people who smoke(cases) were having a risk of developing lung cancer 36 times that of non smokers.
  • 35. Bias • It is any systematic error in the determination of the association between exposure and the disease. a) Bias due to confounding b) Memory or recall bias c) Selection bias d) Berkesonian bias e) Interviewers bias
  • 36. Advantages • Easy to conduct, consume less time, inexpensive. • Suitable for rare disease. • There is no risk to the subjects as disease has already occurred. • It is possible to study different causative factors responsible for a particular disease. • Minimal ethical problem
  • 37. Disadvantages • Study depends upon on history/records/memory. • It is very difficult to get a perfect control. Group. • It is not possible to measure incidence and relative risk. • This study can not distinguish between causes and associated factors
  • 38. 3) COHORT STUDY • Cohort studies also called as Follow up , Incidence study, Prospective study, Forward looking study or longitudinal study. • Cohort study is similar to a longitudinal descriptive study with exception that there is comparison group in cohort. • Cohort is defined as a group of people who share a common characteristics or exposure within a specified time period (Birth cohort).
  • 39. • Cohort studies are indicated when there is good evidence of association between exposure and when exposure is rare and incidence is high. • They are indicated when follow up is easy, cohort is stable, cooperative and easily accessible and ample funds are available. • Cohorts must be free from the disease under study and then they are classified into subgroups according to exposure to a potential cause of disease or outcome. And followed up for study under same identical conditions.
  • 40. • Both groups should be comparable in respect of all the possible variables, which may influence the frequency of disease. • Diagnostic and eligibility criteria of disease must be defined before the study.
  • 41. Types of cohort • 1.Prospective • 2.Retrospective • 3.Mixed
  • 42. Steps of a cohort study 1) Selection of study subjects a) General Population: people residing in well defined geographical area. b) Special groups: such as professional group, governments employees, volunteers, etc. these groups are usually homogeneous population.
  • 43. 2) Obtaining data on exposure: data collected through personal interviews, mailed questionnaires, previous records, medical examination or special tests. • Groups are divided according to whether they have been exposed to a suspected factor (case) or not exposed (control) if yes then divided again as per degree of exposure
  • 44. 3) Selection of comparison group: Internal comparison: In some study no outside comparison group required. On the basis of information obtained single cohort group are classified into several comparison groups according to degree or level of exposure to risk before development of disease.(e.g. smoking, blood pressure) External comparison: when degree or level of exposure is not availble.
  • 45. Comparison with general population: If none available or the difficulties of selecting the study and comparison group.
  • 46. 4) Follow up: It is a most important step. To obtain data for assessing the outcome, the procedures required, A. Periodical medical examination of each member of cohort as it provides more information. B. Reviewing records from physicians and hospitals. C. By surveillance of routine death records. D. Mailed questionnaire, telephone calls and periodic home visits on annual basis.
  • 47. 5) Analysis: In this study, we analysis data by calculating incidence rates of disease for both cohorts, and then estimating relative risk, attributable risk and population attributable risk.
  • 48. Disease present Disease absent Total Cause present a (30) b (70) a+b (100) Cause absent c (10) d (90) c+d (100)
  • 49. 1. Relative Risk: It is defined as the ratio between the incidence of disease among exposed persons and incidence among non exposed. • In above example, Incidence rate among smokers is=30/100 Incidence rate among non smokers is=10/100
  • 50. • Therefore, Relative risk = 30/10 = 3. • Relative risk has etiological enquiries as it provides direct measure of the strength of association between suspected cause or exposure and effect. • In this example, relative risk is 3 means people who smoke cigarettes, have 3 times more risk of developing lung cancers than non smokers.
  • 51. 2. Attributable risk/Risk difference: It is the difference in incidence rates of disease between exposed group and non exposed group. • It provides info. about the contribution of suspected cause for the occurrence of disease. (or how much of the disease can be attributed to suspected cause.)
  • 52. AR = (Incidence of disease in exposed – Incidence of disease in non exposed × 100 Incidence rate among exposed
  • 53. • In this example, AR= 0.3-0.1 × 100 0.3 = 0.2/0.1 × 100 = 66% • So in this example, It shows that, 66% of the lung cancers among smokers could be attributed to smoking. And hence there is a causal association.
  • 54. • This information helps in knowing how much of the disease can be eliminated by eliminating or controlling the suspected cause under study.
  • 55. 3. Population attributable risk: It is the incidence of the disease (or death) in the total population minus incidence of the disease (or death) among those who were not exposed to the suspected causal factor. • It provides an estimate of the amount by which the disease could be reduced in that population if the suspected cause or exposure was eliminated or controlled.
  • 56. Advantages • We find out incidence. • The beginning point is cohort with and without exposure, so from this we can study many outcomes related to exposure. • Relative risk is being calculated. • Minimal bias
  • 57. Disadvantages • Unsuitable for rare diseases. • Time consuming. (migration, death ,behaviour change or loss of interest, population attrition) • Administrative problems( lack of experienced staff, shortage of fund). • Over a period of time, the diagnostic criteria or definition of a disease under study may change. • Expensive.
  • 58. • Selection of comparison groups which are representative of the exposed and unexposed segments of the population is a limiting factor. • Ethical issues.
  • 59. Nested case control study • It is a case control study “nested” within a prospective or retrospective cohort study. • In this study design, Cases and Controls both are from cohort sample. • It is useful for predictor variables that are expensive, useful for costly analysis of specimens, like biochemical analysis of serum samples that are taken at the beginning of the study and then preserved for later analysis.
  • 60. • STEPS : • Identify a cohort with a pool of specimens collected at baseline. • Identify those developing disease during follow up(Cases). • Select the sample from cohort who do not develop the disease(Control) • Measure the predictor variables.
  • 61. 4)Ecological study • Aka correlational study • Useful for generating hypothesis • Units of analysis are groups of people • These studies can be done by comparing populations in different places at same time or in a time series or comparing same population at one place at different time.
  • 62. Drawbacks • As it is easy to conduct, attractive, these study are often difficult to interpret. • Ecological studies usually rely on data collected for other purposes. • The association between exposure and effect at the individual level cant be made. • Ecological fallacy: bias results from if inappropriate conclusions are drawn on the basis of ecological data.

Editor's Notes

  1. Definition: by Dr. John.M.Last
  2. Surveillance: The ongoing systemic collection, analysis and interpretation of health data essential to the planning, implementation and evaluation of public health practice,closely integrated with the timely dissemination of these data to those who need to know. [ centers for disease control and prevention proposed by Langmuir 1963]
  3. Hypothesis: . It provides a tentative explanation for a phenomenon under investigation
  4. that are fixed characteristics of individuals such as ethnicity or blood group. (The study involves looking at people who differ on one key characteristic at one specific point in time.)
  5. Case Control studies are longitudinal.
  6. Data : will be collected from hospital ,workplace or general population
  7. Pertinent – getting attached/affiliated
  8. easily accessible which minimizes the problem of attrition of study population.
  9. Term prospective refers to the timing of data collection